Beta Bionics Inc (NASDAQ: BBNX) Stock Forecast: An Analysis

In the last trading session, 1.21 million Beta Bionics Inc (NASDAQ:BBNX) shares changed hands as the company’s beta touched 0. With the company’s per share price at $13.94 changed hands at -$0.62 or -4.26% during last session, the market valuation stood at $604.44M. BBNX’s last price was a discount, traded about -75.75% off its 52-week high of $24.50. The share price had its 52-week low at $8.89, which suggests the last value was 36.23% up since then. When we look at Beta Bionics Inc’s average trading volume, we note the 10-day average is 0.6 million shares, with the 3-month average coming to 507.24K.

Beta Bionics Inc (NASDAQ:BBNX) trade information

Instantly BBNX was in red as seen at the end of in last trading. With action -11.32%, the performance over the past five days has been red. However, in the 30-day time frame, Beta Bionics Inc (NASDAQ:BBNX) is -19.14% down. Looking at the short shares, we see there were 4.73 million shares sold at short interest cover period of 8.62 days.

The 2025 estimates are for Beta Bionics Inc earnings to increase by 74.29%, but the outlook for the next 5-year period is at 38.94% per year.

BBNX Dividends

Beta Bionics Inc is expected to release its next quarterly earnings report on 2025-May-07.

Beta Bionics Inc (NASDAQ:BBNX)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 6.51% of Beta Bionics Inc shares while 98.41% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 105.26%.

Marketing Sentinel
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.